We are live on ! Find out more
PT

Plimoth Trust Portfolio holdings

AUM $501M
1-Year Est. Return 35.9%
This Fund
S&P 500
This Quarter Est. Return
+0.04%
1 Year Est. Return
+35.9%
3 Year Est. Return
+94.01%
5 Year Est. Return
+113.81%
10 Year Est. Return
–
AUM
$389M
AUM Growth
-$7.54M
Cap. Flow
-$2.84M
Cap. Flow %
-0.73%
Top 10 Hldgs %
34.18%
Holding
164
New
4
Increased
42
Reduced
92
Closed
5

Top Buys

Rank Stock Value
1
NVO
Novo Nordisk
NVO
+$610K
2
SPYG icon
State Street SPDR Portfolio S&P 500 Growth ETF
SPYG
+$229K
3
BBT
Beacon Financial Corp
BBT
+$207K
4
EW icon
Edwards Lifesciences
EW
+$193K
5
IQLT icon
iShares MSCI Intl Quality Factor ETF
IQLT
+$187K

Top Sells

Rank Stock Value
1
CVS icon
CVS Health
CVS
+$541K
2
XLK icon
State Street Technology Select Sector SPDR ETF
XLK
+$382K
3
PGX icon
Invesco Preferred ETF
PGX
+$269K
4
CI icon
Cigna
CI
+$257K
5
AAPL icon
Apple
AAPL
+$252K

Sector Composition

Rank Sector Weight
1 Technology 26.52%
2 Miscellaneous 11.65%
3 Financials 11.08%
4 Healthcare 10.83%
5 Consumer Discretionary 9.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GSK icon
151
GSK
GSK
$100B
$234K 0.06%
6,920
– –
SPYG icon
152
State Street SPDR Portfolio S&P 500 Growth ETF
SPYG
$54.9B
$233K 0.06%
+2,647
New +$229K
SCI icon
153
Service Corp International
SCI
$11.2B
$228K 0.06%
2,860
– –
CPB icon
154
Campbell Soup
CPB
$6.38B
$220K 0.06%
5,265
-115
-2% -$5.2K
HPQ icon
155
HP
HPQ
$29.4B
$215K 0.06%
6,600
-190
-3% -$6.83K
NVS icon
156
Novartis
NVS
$304B
$209K 0.05%
2,148
– –
EW icon
157
Edwards Lifesciences
EW
$51.8B
$205K 0.05%
+2,763
New +$193K
HUM icon
158
Humana
HUM
$48.2B
$204K 0.05%
806
+20
+3% +$5.36K
BBT
159
Beacon Financial Corp
BBT
$2.67B
$204K 0.05%
+7,184
New +$207K
BAX icon
160
Baxter International
BAX
$13.4B
– –
-5,282
Closed -$201K
CI icon
161
Cigna
CI
$74.7B
– –
-742
Closed -$257K
PMX
162
DELISTED
PIMCO Municipal Income Fund III
PMX
– –
-10,124
Closed -$83.6K
XLB icon
163
State Street Materials Select Sector SPDR ETF
XLB
$8.68B
– –
-4,744
Closed -$229K
3 4 5 6
7

Similar funds

FGWP
Founders Grove Wealth Partners Richmond, Virginia $501M AUM 23.49% 1-Year Est. Return
PCA
Peddock Capital Advisors Braintree, Massachusetts $501M AUM 29.8% 1-Year Est. Return
TLP
Trinity Legacy Partners Houston, Texas $500M AUM 23.58% 1-Year Est. Return
HC
Headwater Capital Hong Kong, China $500M AUM 72.8% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
PPL
Planning Project LLC The Woodlands, Texas $501M AUM
WFM
Wolff Financial Management Kalamazoo, Michigan $501M AUM 20.63% 1-Year Est. Return
CM
CoreCommodity Management Stamford, Connecticut $502M AUM 53.83% 1-Year Est. Return

Plimoth Trust's Q4 2024 Portfolio in Review

As of Q4 2024, Plimoth Trust held 164 positions worth $389M, down 1.9% from $397M the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Plimoth Trust's Q4 2024 filing shows 4 new, 42 increased, 92 reduced and 5 closed positions. Its largest new stake was Novo Nordisk: 5,645 shares worth $486K. The largest sale was CVS Health, an estimated $541K.

By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 26% a quarter earlier, followed by Miscellaneous and Financials.

  • Plimoth Trust's largest Q4 2024 buy was Novo Nordisk: 5,645 shares worth $486K.
  • Plimoth Trust added most to iShares MSCI Intl Quality Factor ETF in Q4 2024, an estimated $187K increase.
  • Plimoth Trust's biggest Q4 2024 reduction was CVS Health, cutting an estimated $541K.
  • Plimoth Trust fully exited Cigna in Q4 2024, selling an estimated $257K.
  • Plimoth Trust's ten largest holdings make up 34% of its $389M portfolio in Q4 2024.
  • Plimoth Trust opened 4 new positions and closed 5 in Q4 2024.
  • Plimoth Trust's portfolio value fell 1.9% quarter-over-quarter to $389M.

Based on Plimoth Trust's 13F filing for Q4 2024, filed 23 Jan 2025.